Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST)

British Journal of Cancer

Volumn 96, Issue 11, 2007, Pages 1656-1658

  Nilsson, B ^a   Sjolund K ^a   Kindblom, L G ^a,b   Meis Kindblom, J M ^a,b   Bumming P ^a   Nilsson, O ^a   Andersson, J ^a   Ahlman, H ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Adjuvant treatment; Gastrointestinal stromal tumour (GIST); Imatinib; KIT; Mutation; PDGFRA

Indexed keywords

IMATINIB;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HIGH RISK PATIENT; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PILOT PROJECTS; PIPERAZINES; PROGNOSIS; PYRIMIDINES; RECEPTOR PROTEIN-TYROSINE KINASES; RECURRENCE; RISK FACTORS;

EID: 34249791491     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603797     Document Type: Article

References (8)

1. Andersson J, Bumming P, Meis-Kindblom JM, Sihto H, Nupponen N, Joensuu H, Oden A, Gustavsson B, Kindblom LG, Nilsson B (2006) Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis. Gastroenterology 130: 1573-1581; doi:10.1053/j.gastro.2006.01.043
2. Bumming P, Ahlman H, Andersson J, Meis-Kindblom JM, Kindblom LG, Nilsson B (2006) Population-based study of the diagnosis and treatment of gastrointestinal stromal tumours. Br J Surg 93: 836-843; doi:10.1002/bjs.5350
3. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW (2002) Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33: 459-465, doi:10.1053/hupa.2002.123545
4. Kindblom LG, Meis-Kindblom J, Andersson J, Bumming P, Sihto H, Nupponen N, Joensuu H, Oden A, Gustavsson B, Nilsson B (2006) Reply: prognostic value of KIT exon 11 deletions in GISTs. Gastroenterology 131: 977-978; doi:10.1053/j.gastro.2006.07.035
5. Miettinen M, Lasota J, Sobin LH (2005) Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature. Am J Surg Pathol 29: 1373-1381
6. Nilsson B, Bumming P, Meis-Kindblom JM, Oden A, Dortok A, Gustavsson B, Sablinska K, Kindblom LG (2005) Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-a population-based study in western Sweden. Cancer 103: 821-829; doi:10.1002/cncr.20862
7. Persson S, Kindblom LG, Angervall L, Tisell LE (1992) Metastasizing gastric epithelioid leiomyosarcomas (leiomyoblastomas) in young individuals with long-term survival. Cancer 70: 721-732
8. Verweij J, Casali PG, Zalcberg J, LeCesne A, Reichardt P, Blay JY, Issels R, van Oosterom A, Hogendoorn PC, Van Glabbeke M, Bertulli R, Judson I (2004) Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet 364: 1127-1134; doi:10.1016/S0140-6736(04)17098-0